Brokerages Expect Aphria Inc (NYSE:APHA) to Post -$0.02 Earnings Per Share

Wall Street analysts forecast that Aphria Inc (NYSE:APHA) will report earnings per share of ($0.02) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Aphria’s earnings. Aphria posted earnings per share of $0.07 in the same quarter last year, which would indicate a negative year over year growth rate of 128.6%. The firm is expected to report its next earnings results on Friday, October 11th.

On average, analysts expect that Aphria will report full year earnings of $0.08 per share for the current fiscal year, with EPS estimates ranging from $0.05 to $0.12. For the next fiscal year, analysts anticipate that the company will post earnings of $0.19 per share, with EPS estimates ranging from $0.04 to $0.30. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Aphria.

Aphria (NYSE:APHA) last released its earnings results on Thursday, August 1st. The company reported $0.05 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.10. The company had revenue of $128.60 million during the quarter, compared to analysts’ expectations of $99.26 million. The company’s revenue for the quarter was up 971.7% compared to the same quarter last year.



Several analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Aphria from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 22nd. CIBC lowered shares of Aphria from a “neutral” rating to a “sector underperform” rating in a research report on Friday, July 26th. Finally, ValuEngine raised shares of Aphria from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $13.63.

Shares of NYSE APHA traded down $0.17 during midday trading on Friday, hitting $5.53. The company’s stock had a trading volume of 4,621,264 shares, compared to its average volume of 5,285,291. The stock has a fifty day moving average price of $6.44 and a 200 day moving average price of $7.32. Aphria has a one year low of $3.75 and a one year high of $16.19. The firm has a market capitalization of $1.44 billion, a price-to-earnings ratio of -50.27 and a beta of 2.90.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC increased its holdings in Aphria by 45.3% during the 1st quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock worth $52,000 after acquiring an additional 1,755 shares during the period. Synovus Financial Corp increased its holdings in Aphria by 56.9% during the 2nd quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock worth $39,000 after acquiring an additional 2,000 shares during the period. Shell Asset Management Co. increased its holdings in Aphria by 17.9% during the 1st quarter. Shell Asset Management Co. now owns 17,723 shares of the company’s stock worth $165,000 after acquiring an additional 2,687 shares during the period. Tower Research Capital LLC TRC increased its holdings in Aphria by 76.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock worth $44,000 after acquiring an additional 2,698 shares during the period. Finally, Cetera Advisor Networks LLC increased its holdings in Aphria by 15.1% during the 1st quarter. Cetera Advisor Networks LLC now owns 35,717 shares of the company’s stock worth $340,000 after acquiring an additional 4,684 shares during the period. 10.98% of the stock is currently owned by institutional investors.

About Aphria

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Recommended Story: What does a bar chart display?

Get a free copy of the Zacks research report on Aphria (APHA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aphria (NYSE:APHA)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.